Similar articles

• [Prostaglandins - - clinical aspects in ophthalmology].

  Malcea C, Nenciu A. Malcea C, et al. Oftalmologia. 2006;50(3):22-8. Oftalmologia. 2006. PMID: 17144502 Review. Romanian. No abstract available.
• A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.

  Borghi V, Bastia E, Guzzetta M, Chiroli V, Toris CB, Batugo MR, Carreiro ST, Chong WK, Gale DC, Kucera DJ, Jia L, Prasanna G, Ongini E, Krauss AH, Impagnatiello F. Borghi V, et al. J Ocul Pharmacol Ther. 2010 Apr;26(2):125-32. doi: 10.1089/jop.2009.0120. J Ocul Pharmacol Ther. 2010. PMID: 20415621
• Discovery of 13-oxa prostaglandin analogs as antiglaucoma agents: synthesis and biological activity.

  Feng Z, Hellberg MR, Sharif NA, McLaughlin MA, Williams GW, Scott D, Wallace T. Feng Z, et al. Bioorg Med Chem. 2009 Jan 15;17(2):576-84. doi: 10.1016/j.bmc.2008.11.070. Epub 2008 Dec 6. Bioorg Med Chem. 2009. PMID: 19101156
• Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.

  Shimmyo M. Shimmyo M. Am J Ophthalmol. 2005 Jun;139(6):1148; author reply 1148-9. doi: 10.1016/j.ajo.2005.01.018. Am J Ophthalmol. 2005. PMID: 15953471 No abstract available.
• Studies on ocular inflammation and development of a prostaglandin analogue for glaucoma treatment.

  Stjernschantz J. Stjernschantz J. Exp Eye Res. 2004 Apr;78(4):759-66. doi: 10.1016/j.exer.2003.11.016. Exp Eye Res. 2004. PMID: 15037110 Review.